Cover Story
By Matthew Bin Han Ong
Nearly 100 cancer patients and others gather for a march to University of Utah President David Pershing's office on April 24, calling for the reinstatement of Mary Beckerle as director and CEO of the Huntsman Cancer Institute.Cover Photo by Scott G Winterton, Deseret NewsA week after her abrupt firing, Mary Beckerle is back in her job as director and CEO of the Huntsman Cancer Institute.
In Brief
Drugs & Targets
Trending Stories
- What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.” - Trump 2016: A look back at the 45th president’s impact on oncology
- A study measures the long-term downside of prostate cancer screening
A paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment - At an uncertain time for cancer research and public health, Wayne Frederick steps in as interim CEO at ACS
- GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation
- How the 2024 elections can impact cancer policy